Home / Compliance Framework
/ 5A. Prohibited Activities
1. Purpose & Jurisdiction
This document outlines strictly prohibited activities across all Aevum Zenth subsidiaries, joint ventures, and contracted partners. Violations are subject to immediate contract termination, regulatory reporting, and legal action under international compliance frameworks including ISO 37301, SOX, GDPR, and UN Global Compact principles.
2. Financial & Legal Violations
2.1 Anti-Money Laundering (AML) Breaches
- Structuring transactions to avoid reporting thresholds
- Facilitating unverified cross-border capital flows
- Using shell entities to obscure beneficial ownership
2.2 Sanctions & Export Control Violations
- Trading with OFAC, UN, or EU listed entities
- Diverting controlled technologies to restricted jurisdictions
- Falsifying end-user certificates or license applications
2.3 Market Manipulation & Insider Trading
- Trading on material non-public information
- Coordinated wash trading or spoofing across divisions
- Unlawful price-fixing or bid-rigging among subsidiaries
3. Technological & Data Misuse
3.1 Unauthorized Data Access & Exfiltration
- Bypassing IAM controls or privilege escalation
- Copying or transmitting classified IP to unapproved storage
- Selling or licensing proprietary algorithms without clearance
3.2 AI & Autonomy Boundary Violations
- Deploying untested autonomous systems in safety-critical environments
- Fabricating or poisoning training datasets for regulatory submission
- Bypassing human-in-the-loop requirements for defense aerospace modules
3.3 Cybersecurity & Infrastructure Negligence
- Intentional bypass of SIEM or incident response protocols
- Sharing root credentials or multi-factor bypass mechanisms
- Unauthorized penetration testing or fuzzing on production grids
4. Aerospace, Industrial & Environmental Hazards
4.1 Unregulated Aerospace Operations
- Launching or tracking hardware without ICAO/FAA coordination
- Interfering with satellite frequency allocations or telemetry links
- Operating propulsion systems beyond certified safety margins
4.2 Environmental & Resource Exploitation
- Discharging untreated byproducts into protected hydrological zones
- Clearing biodiversity corridors without EPA/EU permits
- Mining critical minerals in UN-designated protected territories
5. Healthcare & Bioethics Restrictions
5.1 Unapproved Clinical & Genetic Operations
- Conducting trials outside IRB/EMA/FDA regulatory oversight
- Modifying heritable genomes without multijurisdictional ethics clearance
- Selling or sharing unvalidated diagnostic biomarkers commercially
5.2 Pharmaceutical & Medical Device Diversion
- Redirecting controlled substances to unlicensed distributors
- Selling FDA-cleared implants as experimental prototypes
- Falsifying sterilization or biocompatibility test logs
6. General Corporate Conduct
- Accepting or offering bribes, facilitation payments, or undisclosed kickbacks
- Engaging in conflicts of interest without full disclosure to the Compliance Committee
- Retaliating against whistleblowers or internal auditors
- Using Aevum Zenth branding for unregistered third-party ventures
- Misrepresenting subsidiary financials in investor or regulatory filings
⚠️ Enforcement Protocol
All violations are logged in the centralized Compliance Ledger. Confirmed breaches trigger immediate operational suspension, forensic audit, regulatory notification, and potential civil or criminal referral. Repeated or severe violations result in permanent blacklisting from all Aevum Zenth contracts, partnerships, and talent networks.